Heusser et al., “Therapeutic Potential of anti-IgE Antibodies”, Current Opinions in Immunology 9(6):805-813 (1997). |
Hook, W.A., et al., “Monoclonal Antibodies Defining Epitopes on Human IgE”, Mol. Immunol. 28(6):631-639 (1991). |
Spiegelberg, et al., “Inhibition of IgE formation and allergic inflammation by allergen gene immunization and by CpG motif immunostimulatory oligonucleotides” Allergy vol. 53, pp. 93-97 (Sep. 1998). |
Voo, K.S. et al., Cloning of a Mammalian Transcriptional Activator That Binds Unmethylated CpG Motifs and Shares a CXXC Domain with DNA Methyltransferase, Human Trithorax, and Methyl-CpG Binding Domain Protein 1, Mol. Cell Biol. 20(6):2108-2121 (2000). |
Kreig, A.M., The Role of CpG Motifs in Innate Immunity, Crr. Opin. Immunol. 12:35-43 (2000). |
McDonnell, J.M. et al., “Structure based design and characterization of peptides that inhibit IgE binding to its high affinity receptor,” Nature Struct. Biol. 3(5):419-426 (1996). |
Weigand, T.W. et al., “High Affinity Oligonucleotide Ligands to Human IgE Inhibit Binding to Fcε Receptor I,” J. Immunol. 157:221-230 (1996). |